
$22.34M | |
-- | |
$19.65 | |
$13.43 | |
$17.82 | |
$0.00 | |
+8.50% | |
-- |
Faeth Therapeutics, Inc. (FTH) is currently trading at $0.00 as of null, reflecting a +8.50% move ($-0.00) from the previous close.
In the short term, the stock has returned +22.64% over the past four weeks. Over the last 12 months, Faeth Therapeutics, Inc. has recorded a +22.64% price change, indicating a Strong performance relative to the broader market.
Over the past seven days, Faeth Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $13.49 to the latest recorded price of $0.00, reflecting an intraday change of +8.50%. Daily movements highlight shifts in trading volume (0), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, FTH has delivered a +22.64% return over the past month and a +22.64% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.
You can buy and trade FTH on MEXC in three simple steps:
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
| Industry | -- |
| Employees | 29 |
| Sector | -- |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 FTH = 0 USD